Dr. Hamed Khosravi, MD

Dr. Khosravi practices at Northern Virginia Hematology Oncology Associates in Woodbridge, Virginia.

Dr. Khosravi's NPI, 1407802671, was assigned on May 26, 2006. Dr. Khosravi holds Virginia license 0101236341.

Dr. Khosravi's primary practice is Northern Virginia Hematology Oncology Associates, at 2079 Daniel Stuart Sq, Woodbridge, VA 22191 in Prince William County. The practice phone is (703) 491-5600.

Dr. Khosravi's primary practice is Northern Virginia Hematology Oncology Associates in Woodbridge, Virginia. Dr. Khosravi is also affiliated with Sentara Northern Virginia Medical Center. The medical group on file is Northern Virginia Hematology & Oncology Associates. Dmand AI also links Dr. Khosravi to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khosravi practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Khosravi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Khosravi's licenses on file in 2 states: Virginia and Maryland.

CMS data shows 30,163 Medicare services from Dr. Khosravi across 37 procedure codes in 2024, for 390 Medicare patients. Medicare paid $386,829 for them.

CMS counts 390 Medicare patients who saw Dr. Khosravi in 2024. The largest group is 65 to 74, with 157 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khosravi's median patient age at 68, with 53% women.

In 2024, Dr. Khosravi wrote 358 Medicare Part D claims for 89 patients. 53% of them were for generic drugs. CMS names the drug for 140 of them, across 10 drugs with 11 or more claims each, at $616,753 in total drug cost. In 2023, CMS named 255 claims across 15 drugs.

Dr. Khosravi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Khosravi, published from 2022 to 2025. The most frequent topics are Skin Neoplasms. Dr. Khosravi's most frequent co-authors are Amir A. Bajoghli, MD and Michael Andrew Cardis, MD.

CMS Open Payments shows 799 general payments to Dr. Khosravi from 87 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. Celgene Corporation paid the most, $6,884.